G protein-coupled receptor fusion proteins in drug discovery

Milligan, G., Feng, Gui Jie, Ward, R., Sartania, N., Ramsay, D., McLean, A. and Carrillo, J. 2004. G protein-coupled receptor fusion proteins in drug discovery. Current Pharmaceutical Design 10 (17) , pp. 1989-2001. 10.2174/1381612043384295

Full text not available from this repository.

Abstract

A wide range of peptides and polypeptides can be appended to either the N- or C-terminus of G proteincoupled receptors without disrupting substantially ligand binding and signal transduction. Following fusion of fluorescent proteins, reporter gene constructs or G protein α subunits to the C-terminal tail of a receptor high content and G protein activation assays can be employed to identify agonist ligands. Further modification of the receptor fusions to introduce enhanced levels of constitutive activity and to physically destabilise the protein allows antagonist / inverse agonists screens to be developed in parallel. Equivalent C-terminal addition of pairs of complementary, non-functional, polypeptide fragments allows the application of enzyme complementation techniques. Introduction of N-terminal tags to receptors has also allowed the introduction of novel assay techniques based on a pH-sensitive cyanine dye. These have the capacity to overcome certain limitations of GPCR-fluorescent protein fusions.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences European Cancer Stem Cell Research Institute (ECSCRI)
Publisher:	Bentham Science Publishers
ISSN:	1381-6128
Last Modified:	17 Jan 2019 09:41
URI:	https://orca.cardiff.ac.uk/id/eprint/66418

Citation Data

Cited 42 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item